SCHEMBL7206519

SCHEMBL7206519

CCOC(=O)[C@H](CS)NCc1ccccc1OC(C)=O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ITGA4 P13612 1/20 0.42
ITGB7 P26010 1/20 0.42
ATM Q13315 2/20 0.39
L3MBTL1 Q9Y468 2/20 0.39
POLB P06746 1/20 0.39
ALDH1A1 P00352 2/20 0.39
KDM4E B2RXH2 3/20 0.38
HSD17B10 Q99714 3/20 0.38
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
PTGS2 P35354 3/20 0.38
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
HTT P42858 2/20 0.37
MAPT P10636 1/20 0.37
HPGD P15428 3/20 0.37
TSHR P16473 2/20 0.37
TDP1 Q9NUW8 2/20 0.37
ESR1 P03372 1/20 0.37
ITGB3 P05106 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7206518 1.00 ITGA4 (0.42) ITGA4ITGB7ATML3MBTL1POLB
SCHEMBL3855374 0.85 L3MBTL1 (0.45) ITGA4ITGB7ATML3MBTL1POLB
SCHEMBL3855371 0.85 L3MBTL1 (0.45) ITGA4ITGB7ATML3MBTL1POLB
SCHEMBL3858901 0.85 ITGA4 (0.44) ITGA4ITGB7ATML3MBTL1POLB
SCHEMBL3858906 0.85 ITGA4 (0.44) ITGA4ITGB7ATML3MBTL1POLB
SCHEMBL3864783 0.84 ITGA4 (0.51) ITGA4ITGB7ATML3MBTL1ALDH1A1
SCHEMBL3862081 0.84 ITGA4 (0.51) ITGA4ITGB7ATML3MBTL1ALDH1A1
SCHEMBL7205432 0.83 ITGA4 (0.38) ITGA4ITGB7ATML3MBTL1POLB
SCHEMBL7205429 0.83 ITGA4 (0.38) ITGA4ITGB7ATML3MBTL1POLB
SCHEMBL3864432 0.80 ITGA4 (0.42) ITGA4ITGB7ATML3MBTL1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6613937-B2 In particular for transdermal, oral, rectal and inhalational application TSIKAS DIMITRIOS (DE) 2003-09-02 US disclosed
US-20020091102-A1 S-nitroso- and S-nitro-N-acyl-L-cysteine ester derivatives as pharmalogically active agents and pharmaceutical compositions containing said compounds TSIKAS DIMITRIOS (DE) 2002-07-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020091102-A1 S-nitroso- and S-nitro-N-acyl-L-cysteine ester derivatives as pharmalogically active agents and pharmaceutical compositions containing said compounds NNMT, NNT, CBS ITGA4 3673/4885ITGB7 3668/4885ATM 3372/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.